Dr. Mora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 West 15th Street
Suite 202
Plano, TX 75093Phone+1 972-943-5914Fax+1 940-295-4931
Summary
- Dr. Pablo Mora is a seasoned Endocrinologist, based in Plano, TX, with specific expertise in Diabetes.
He received his medical degree from the Universidad de Costa Rica Faculty of Medicine in 1986, and subsequently undertook a fellowship in Endocrinology, Diabetes, and Metabolism at the University of Texas Southwestern Medical Center. His past employment history includes Clinical Faculty with UT Southwestern Medical Center @Dallas, the Cleveland Clinic Florida, Diabetes America (Plano) and Dallas Diabetes Research Center @Medical City Dallas.. Dr. Mora has several recognized publications in the field of Diabetes, focusing on topics such as insulin delivery, mHealth technologies, and other injectable medications with emphasis in type 1 diabetes therapeutics.
He is currently a Clinical Professor of Medicine at the Division of Endocrinology UT Southwestern @Dallas, a Principal Investigator with Tekton Research (McKinney/Irving sites) and Clinical Diabetes Specialist with the North Texas Diabetes in Plano, TX.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994
- Universidad de Costa Rica Faculty of MedicineClass of 1986
Certifications & Licensure
- TX State Medical License 1995 - 2026
- FL State Medical License 2012 - 2014
- OK State Medical License 1992 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- The critical elements of digital health in diabetes and cardiometabolic care.Mansur Shomali, Pablo Mora, Grazia Aleppo, Malinda Peeples, Abhimanyu Kumbara
Frontiers in Endocrinology. 2024-01-01 - 5 citationsEfficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device...Pablo F. Mora, David R. Sutton, Ashwini Gore, Bantwal Baliga, Rebecca F. Goldfaden
BMJ Open Diabetes Research & Care. 2020-11-01 - EFFICACY AND SAFETY OF IGLARLIXI IN HISPANICS AND NON-HISPANIC WHITES WITH TYPE 2 DIABETES.Pablo F. Mora, Jason Chao, Aramesh Saremi, Terry Dex, Michelle Roberts
Endocrine Practice. 2019-06-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: